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Abstract
Background: The guanine nucleotide binding protein (G protein)-coupled receptors (GPCRs) regulate cell growth,
proliferation and differentiation. G proteins are also implicated in erythroid differentiation, and some of them are
expressed principally in hematopoietic cells. GPCRs-linked NO/cGMP and p38 MAPK signaling pathways already
demonstrated potency for globin gene stimulation. By analyzing erythroid progenitors, derived from hematopoietic
cells through in vitro ontogeny, our study intends to determine early markers and signaling pathways of globin
gene regulation and their relation to GPCR expression.
Results: Human hematopoietic CD34+ progenitors are isolated from fetal liver (FL), cord blood (CB), adult bone
marrow (BM), peripheral blood (PB) and G-CSF stimulated mobilized PB (mPB), and then differentiated in vitro into
erythroid progenitors. We find that growth capacity is most abundant in FL- and CB-derived erythroid cells. The
erythroid progenitor cells are sorted as 100% CD71+, but we did not find statistical significance in the variations of
CD34, CD36 and GlyA antigens and that confirms similarity in maturation of studied ontogenic periods. During
ontogeny, beta-globin gene expression reaches maximum levels in cells of adult blood origin (176 fmol/μg), while
gamma-globin gene expression is consistently up-regulated in CB-derived cells (60 fmol/μg). During gamma-globin
induction by hydroxycarbamide, we identify stimulated GPCRs (PTGDR, PTGER1) and GPCRs-coupled genes known
to be activated via the cAMP/PKA (ADIPOQ), MAPK pathway (JUN) and NO/cGMP (PRPF18) signaling pathways.
During ontogeny, GPR45 and ARRDC1 genes have the most prominent expression in FL-derived erythroid
progenitor cells, GNL3 and GRP65 genes in CB-derived cells (high gamma-globin gene expression), GPR110 and
GNG10 in BM-derived cells, GPR89C and GPR172A in PB-derived cells, and GPR44 and GNAQ genes in mPB-derived
cells (high beta-globin gene expression).
Conclusions: These results demonstrate the concomitant activity of GPCR-coupled genes and related signaling
pathways during erythropoietic stimulation of globin genes. In accordance with previous reports, the stimulation of
GPCRs supports the postulated connection between cAMP/PKA and NO/cGMP pathways in activation of γ-globin
expression, via JUN and p38 MAPK signaling.
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Background
The guanine nucleotide binding protein (G protein)-
coupled receptor (GPCRs) family represents the largest
group of cell surface receptors that regulate cell growth,
proliferation, and differentiation [1]. The silencing of
Gpr48, as GPCR is highly expressed in the fetal liver
(FL) and premature erythroblast, has no effects on
primitive erythropoiesis but significantly reduces de-
finitive erythropoiesis through the cAMP/PKA/CREB
pathway [2]. Inactivation of Gpr48 induces remarkable
decreases in the proliferation of definitive erythroid
progenitors and erythroblast islands in FL [2]. GPCRs are
linked via G proteins to adenylyl cyclase, phospholipases,
and ionic conductance channels [3]. Thus, the Gαs pro-
tein is known to couple GPCRs to adenylyl cyclase to
stimulate formation of the second messenger cAMP. It
has been found that, upon activation of the cAMP path-
way, expression of the gamma (γ)-globin gene is induced
in adult erythroblasts [4]. Once formed, cAMP consecu-
tively stimulates cAMP-dependent protein kinase (PKA).
According to our previous results, cytostatic hydroxy-
carbamide (hydroxyurea) also induces phosphorylation of
endothelial nitric oxide synthase (eNOS) in a PKA-
dependent manner [5]. Hydroxycarbamide, as a γ-globin
inducer, increases intracellular cAMP levels as well as
cGMP levels in human erythroid progenitor cells [6]. Fetal
hemoglobin induction by hydroxycarbamide is mediated
by the nitric oxide (NO)-dependent activation of soluble
guanylyl cyclase (sGC) [7].
G proteins also couple the receptors to other cellular
effectors systems. Thus, Gαo has been shown to link
GPCRs to Ca2+ conductance channels to regulate the
influx of Ca2+ to cells [8]. Hydroxycarbamide-induced rise
in intracellular Ca2+ demonstrates dependence on the cal-
cium leak from endoplasmic reticulum [5]. In addition to
G proteins, GPCRs also couple with β-arrestins involved
in termination of receptor activation after prolonged
agonist binding [9]. Furthermore, β-arrestins facilitate the
internalization of GPCRs, followed by ubiquitination and
proteasome degradation with consequential GPCR down-
regulation [10]. We showed that hydroxycarbamide inhi-
bited the proteasome activity, which also supports the
correlation between GPCRs and globin genes control [11].
Several groups have examined the gene expression
profile of human CD34+ hematopoietic progenitor cells
from bone marrow (BM), peripheral blood (PB) and cord
blood (CB) using microarray technology [12,13]. The
modulation of gene expression during ontogeny in FL-
and CB-derived hematopoietic progenitor cells appears
to overlap largely with early response genes of growth
factor stimulated adult BM hematopoietic progenitor
cells [14]. Recent studies have begun to define general
gene expression profiling of human erythroid cells from
different origins - adult BM and PB [15,16]. In general, it
has been hypothesized that globin gene switching may
be mediated by proteins expressed during different
stages of ontogeny.
A previous report demonstrated that stromal feeder
layers of human FL, CB, and adult BM did not change
hemoglobin types during erythroid differentiation of
CD34+ hematopoietic progenitor cells derived from the
equivalent tissues [17]. Instead of this approach, we
perform erythroid differentiation of only CD34+ hemato-
poietic progenitor cells originated from fetal to adult
hematopoietic cells. The erythroid cells growth and
differentiation markers have been determined in in vitro
liquid cultures. The γ-globin gene expression is the most
increased in CB-derived erythroid cells, while beta (β)-
globin gene expression is the highest in adult blood cells
(BM, PB) during erythroid differentiation. We compare
the G proteins and GPCRs gene expression at several
stages in ontogeny by array analyses. During γ-globin
induction, we identify GPCRs related genes that were
activated via the cAMP/PKA, p38 MAP kinase and NO/
cGMP signaling pathways.
Results
Characterization of erythroid cell cultures
Growth potential of CD34+ hematopoietic progenitor
cells is determined by counting the viable cells. Growth
capacity is found to be most abundant for FL-derived
CD34+ cells during erythroid differentiation. CB- and
mPB-derived CD34+ cells have a higher cell growth poten-
tial than BM- and PB-derived cells during early erythroid
differentiation (Figure 1A). In the presence of EPO and
other cytokines, CD34+ cells are differentiated in vitro into
erythroid progenitor cells, confirmed by flow cytometry
analysis using four different markers: CD34, CD36, CD71
and GlyA (Figure 1B,C). The transferrin receptor (CD71)
is present at early erythroid cells and disappears as
reticulocytes differentiate into mature erythrocytes [7]. At
day 6 of erythroid cell culture, the erythroid progenitor cells
are sorted as 100% CD71+, a well-known early marker of
erythroid differentiation. Erythroid progenitor cells from all
examined cells, except from FL-derived, retain high levels
of CD34 antigen expression (about 50–60%). Moreover, all
of them and particularly erythroid cells of CB and BM
origin, express CD36 antigen (50–70%) also present at early
erythroid cells (Figure 1B). We did not find statistical
significance in the percentage of CD34, CD36 and GlyA
antigen positive cells among erythroid progenitors derived
from examined hematopoietic cells (Figure 1B). Besides
flow cytometry for analysis of in vitro erythroid differenti-
ation, we already reported measurement of hemoglobin
content by benzidine staining and high-performance liquid
chromatography in erythroid progenitor cells during their
in vitro differentiation in the same culture conditions [6,7].
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Globin genes expression during erythroid differentiation
In erythroid progenitor cells derived from PB, γ- and β-
globin gene expression is initially similar, but during
erythroid maturation β-globin gene expression becomes
elevated in erythroid precursor cells and mature eryth-
roid cells (Figure 2A). We already described erythroid
differentiation stages, using erythroid specific cell surface
markers [7]. The γ-globin gene expression in erythroid
cells, of FL origin, has stable expression during erythroid
differentiation (about 20 fmol/μg), whereas erythroid
cells of CB demonstrate elevation (about 60 fmol/μg).
The γ-globin gene expression of adult hematopoietic
progenitor-derived erythroid cells demonstrates reduc-
tion during differentiation reaching minimum at day 14
(3–15 fmol/μg), while its expression was at maximum in
CB-derived erythroid cells (Figure 2B). The β-globin
gene expression is almost absent in erythroid progeni-
tors of FL origin, whereas its expression is slightly
increased in erythroid cells of CB origin (35 fmol/μg at
day 14) and reaches maximum in cells of adult blood
origin: BM (176 fmol/μg) and PB (110 fmol/μg) (Figure 2C).
To compare quantitative PCR results and microarray data
of γ-globin gene expression, we combine them to demons-
trate their expected similar tendencies during ontogeny
(Figure 2D). At day 6 of erythroid culture, the γ-globin
gene expression is the most elevated in CB- and PB-
derived erythroid progenitors, as determined by quantita-
tive PCR. The lowest level of γ-globin gene expression is in
BM-derived erythroid progenitors, as determined by
microarray (Figure 2D).
Effect of hydroxycarbamide on G protein-coupled
receptor signaling pathways in human erythroid
progenitor cells
It has been reported that hydroxycarbamide, a γ-globin
inducer, activated p38 mitogen-activated protein kinase
(MAPK) and c-jun expression [18]. Since these pathways
are also activated by GPCRs, we are interested to deter-
mine additional related pathways in PB-derived erythroid
progenitor cells in a steady state and after incubation with
hydroxycarbamide using GPCRs Signaling Pathway Finder
Gene Array at day 6 of erythroid culture (Table 1). In
the steady state, we find elevated gene expression of
DRD5, S1PR2, PTGDR and PTGER1 in human erythroid
progenitor cells (Figure 3A). We also find increase in
gene expression activated by the cAMP/PKA pathway
Figure 1 Cell growth and differentiation of erythroid cells through ontogeny. (A) During erythropoiesis, the cell growth capacity was
compared with number of seeded cells in the beginning of culture as fold induction of cell growth on a logarithmic scale. *P < 0.05 FL- versus
mPB- and **P < 0.01 FL-derived erythroid cells versus all other cells. (B) Flow cytometry of erythroid progenitor cells, sorted as 100% CD71+ cells
(gated on live CD71+ cells), is determined at day 6 of erythroid cultures. Values are mean ± SEM (n=2-4). (C) Histograms of CD34, CD36 and GLYA
antigen expression on CD71+ sorted cells in a representative experiment at day 6 of erythroid cell culture. Values are positive cells for each
marker expressed in percentage (%) of maximal number of cells.
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(ADIPOQ), PKC pathway (LHB and ELK4), MAPK
pathway (YWHAZ), NO-cGMP pathway (PRPF18) and
JAK-STAT pathway (HSPA4, SOCS1 and HSP90AA1).
HSP90AA1 has the steady upregulated levels during
ontogeny in erythroid cells, as well as HSPA4 and
YWHAZ gene expression (not shown). Hydroxycarbamide
treatment of erythroid progenitor cells induces the
statistically significant expression of following GPCRs:
PTGDR (1.9 fold), and PTGER1 genes (1.9 fold, Figure 3B).
Hydroxycarbamide also stimulates gene expression acti-
vated by cAMP/PKA pathway (ADIPOQ, 3.1 fold), NO/
cGMP pathway (PRPF18, 2.6 fold), MAPK pathway (JUN,
1.6 fold) and JAK-STAT pathway (SOCS1, 2.7 fold,
Figure 3B). Hydroxycarbamide increases γ-globin gene
expression up to 2.5 fold in erythroid progenitor cells used
for GPCRs Gene Array, as measured by real-time quanti-
tative PCR [7]. Gene expression of IL8, upregulated by
hydroxycarbamide, is also elevated in erythroid cells
during ontogeny and more prominent in BM tissue, as
determined by microarray analysis (not shown).
G-protein related genes in erythroid progenitor cells
during ontogenesis
The G protein superfamily consists of heterotrimeric
complexes of distinct α-, β-, and γ-subunits. Heterotrimeric
G proteins are classified according to α subunit into four
subfamilies: Gs, Gi, Gq, and G12/13 [3]. To distinguish
significant G proteins and GPCRs during erythropoiesis we
performed microarray analysis of erythroid progenitor cells
in certain stages of human ontogeny. During microarray
analysis the genes are upregulated or downregulated versus
reference HuURNA, what we use as a control alongside
each sample. G-protein related genes: GNAI2 and GNB1
are continuously downregulated vs. GNB2L1 upregulation
during ontogeny (Figure 4). GNAI3 gene expression was
prominently upregulated in BM- and mPB-derived cells,
but downregulated in FL-derived cells. Steady upregulation
also demonstrates GNL2 and GNL3 genes. The increased
GNG10 and GRK6 gene expression is observed in BM-
derived cells (Figure 4), with elevated β-globin gene ex-
pression (Figure 2C). The expression of GNAQ gene is
Figure 2 Measurement of globin genes expression during human erythroid differentiation. (A) Expression of γ- and β-globin genes during
erythroid differentiation of CD34+ cells derived from normal human PB (n=10). (B) Expression of γ-globin gene during erythroid differentiation of
hematopoietic CD34+ progenitors of FL, CB, BM, PB and mPB origin (n=2-4). *P < 0.05 PB vs FL at day 6, **P < 0.01 CB vs. all other tissues at day
14. (C) Expression of β-globin gene during erythroid differentiation (n=2-4). **P < 0.01 FL-, CB-derived erythroid cells vs. all other cells at day 6, 10
and 14, except #P < 0.05 CB vs. mPB at day 6; *P < 0.05 PB vs. BM at day 14; ##P < 0.01 mPB vs. BM. (D) Comparative expression of γ-globin genes
of erythroid progenitor cells as measured by real time quantitative PCR and microarray analysis at day 6 of liquid culture (n=2-4). ). *P < 0.05 PB
vs. FL by qPCR, #P < 0.05 BM vs. PB by microarray. Values are mean ± SEM.
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significantly increased only in erythroid progenitors of mPB
origin. In addition, GPCRs genes: GPR65 gene has de-
creased gene expression only in BM-, whereas GPR135 only
in PB-derived cells. GPR45 gene has elevated expression in
erythroid cells of FL origin, whereas GPR108 has decreased
expression in BM-derived cells, opposite to GPR110 and
GPR172A genes. In addition, β-arrestins are involved in ter-
mination of GPCRs activation after prolonged agonist bind-
ing [9]. ARRDC1 gene expression is the most upregulated
in FL- and downregulated only in mPB-derived cells,
whereas ARRDC2 expression is decreased in all examined
erythroid progenitors except of BM origin (Figure 4). The
microarray data discussed in this publication we deposited
in NCBI’s GEO database and are accessible through GEO
Series accession number GSE37869 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE37869).
Discussion
To reveal the essential mechanisms in erythropoiesis
several studies have performed gene expression profiling
in erythroid cells from hematopoietic tissues through
ontogeny. The findings in these reports are heteroge-
neous, reflecting the variation in the experimental
systems used. By choosing early erythroid progenitors
differentiated from purified CD34+ cells, we extend
those studies to evaluate globin gene expression in
correlation to GPCR-coupled genes from fetal to adult
erythropoiesis. The γ-globin gene expression is most
prominent in CB-derived erythroid progenitors, whereas
β-globin gene expression is major in adult blood-derived
(BM, PB, mPB), low in CB-derived and almost com-
pletely absent in FL-derived erythroid progenitors. The
GPCR-coupled genes have been studied in erythroid
Table 1 Human G protein-coupled receptor signaling pathway profile in erythroid progenitor cells, of peripheral blood
origin, after treatment with hydroxycarbamide
UniGene Symbol Description Gene expression
G protein-coupled receptors: Control±SD HU±SD p
Hs.2551 ADRB2 Beta 2 adrenergic receptor 0,04±0,04 0,15±0,1 0.107
Hs.2624 DRD1 D1 dopamine receptor 0,12±0,1 0,34±0,2 0.1206
Hs.73893 DRD2 D2 dopamine receptor 0,13±0,02 0,28±0,1 0.0715
Hs.380681 DRD5 D5 dopamine receptor 1,23±0,4 2,03±1,1 0.2115
Hs.458474 S1PR2 Sphingosine-1-phosphate receptor 2 1,92±0,4 2,6±1,1 0.2614
Hs.306831 PTGDR Human DP prostanoid receptor 0,39±0,1 0,76±0,1 0.0391
Hs.159360 PTGER1 Prostaglandin E receptor 1, EP1 subtype 1,02±0,2 1,89±0,5 0.0305
PI-3 kinase pathway:
Hs.525622 AKT1 v-akt murine thymoma viral oncogene homolog 1 0,04±0,01 0,07±0,06 0.139
cAMP/PKA pathway:
Hs.80485 ADIPOQ Adiponectin, C1Q and collagen domain containing 0,28±0,09 0,87±0,2 0.0432
NO/cGMP pathway:
Hs.161181 PRPF18 PRP18 pre-mRNA processing factor 18 homolog 0,36±0,28 0,93±0,6 0.0497
PKC pathway (Ca2+,MEK, etc.):
Hs.154704 LHB Luteinizing hormone beta polypeptide 0,8±0,1 1±0,4 0.1705
Hs.25292 JUNB Jun B proto-oncogene, 0,08±0,08 0,12±0,1 0.0915
Hs.624 IL8 Interleukin 8 0,07±0,04 0,24±0,3 0.1875
Hs.497520 ELK4 ETS-domain protein (SRF accessory protein 1) 0,69±0,12 0,56±0,2 0.1441
JAK-STAT pathway:
Hs.90093 HSPA4 Heat shock 70 kDa protein 4 0,34±0,1 0,35±0,14 0.4318
Hs.525600 HSP90AA1 Heat shock 90 kDa protein 1, alpha 1,84±0,5 2,21±1,2 0.3635
Hs.50640 SOCS1 Suppressor of cytokine signaling 1 0,84±0,4 2,25±0,96 0.0341
Hs.364941 HSD3B1 Hydroxy-delta-5-steroid dehydrogenase 0,09±0,02 0,17±0,03 0.005
MAP kinase pathway (p42/p44MAP, p38MAP):
Hs.414795 SERPINE1 Plasminogen activator inhibitor, type I 0,11±0,1 0,13±0,06 0.3309
Hs.525704 JUN v-jun avian sarcoma virus 17 oncogene homolog 0,13±0,04 0,21±0,01 0.0193
Hs.492407 YWHAZ Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 1,36±0,3 1,28±0,3 0.3155
Hs.285354 MAX Human helix-loop-helix zipper protein 0,05±0,01 0,21±0,2 0.1637
HU – hydroxycarbamide, p – P value of paired t test of Control vs. HU.
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progenitor cells during stimulation of γ-globin gene
production. Hydroxycarbamide stimulates the expression
of several genes (ADIPOQ, SOCS1, HSP90AA1, PRPF18)
activated by GPCRs via cAMP/PKA, p38 MAPK, and
NO/cGMP signaling pathways. A certain number of G-
proteins (α, β, γ isoforms) and GPCRs demonstrate
variation or stability of gene expression in erythroid
progenitor cells during ontogeny. Genes GPR45 and
ARRDC1 have the most prominent expression in FL-
derived, genes GNL3 and GRP65 in CB-derived (with high
γ-globin gene expression), GNL2, GPR110, ARRDC2 and
GNG10 in BM-derived (with β-globin gene expression),
GNAQ, GNA13 and GPR44 in mPB-derived, GPR89C and
GPR172A in PB-derived erythroid progenitors.
As previously reported, G protein expression and
MAPKs are involved in hemin-induced erythroid differ-
entiation, another γ-globin stimulator [19]. Hydroxy-
carbamide increased phosphorylation of p38 in erythroid
differentiation [18]. In accordance with hydroxycarba-
mide and G protein linked activity, Gα12/13 also induced
activation of p38 MAPK (Figure 5) [20]. It has been
revealed that the p38 activation resulted in the stimula-
tion of NF-kappaB-specific DNA-protein binding and
the subsequent expression of inducible NOS and NO
release [21]. Moreover, G protein α12 (GNA12) stimula-
tion of the eNOS protein expression is in accordance
with hydroxycarbamide induction of eNOS protein levels
(Figure 5) [11,22]. We have previously shown that fetal
hemoglobin stimulation, by hydroxycarbamide, is depen-
dent on NO/cGMP signaling pathway in erythroid
progenitor cells [7]. In addition, the activated G protein
α13 (GNA13) induced the NF-kappaB accompanied by
augmented secretion of IL-8 (Figure 5) [23]. Induced
expression of IL-8, HSPA4, SERPINE1 and JUN by
hydroxycarbamide, achieved in our experiments, is also
observed upon hemin-induced erythroid differentiation
[24]. It has been reported that hydroxycarbamide
increased JUN gene and protein expression in erythroid
cells, by increasing the rate of synthesis as well as
stabilizing the mRNA [25]. Initial EPO-dependent JunB
induction was not sufficient, but the late EPO-
independent JunB expression was necessary for differen-
tiation of primary erythroid cells [26]. GNA13 gene
expression has been elevated in erythropoiesis through-
out ontogeny, while GNA12 gene expression is pro-
minent in erythroid progenitors of adult cells origin
(Figure 4).
The G-protein α15 (GNA15) is expressed particularly
in hematopoietic cells [27]. Beta 2-adrenergic receptor
(ADRB2), induced by hydroxycarbamide, can specifically
couple to GNA15 upregulated in erythroid progenitors
of CB and adult cells origin in our microarray study
[28]. It has been reported that calcium-sensing receptor-
mediated MAP kinase (ERK1/2) activation requires
GNAI2 coupling [29]. Inhibition of the ERK pathway
lead to increased hemoglobin levels [30]. Furthermore,
according to our results GNAI2 gene expression is de-
creased in every examined erythroid progenitors. The
activation of p38 MAPK signaling pathway, induced by
GNA12/13, is also involved in butyrate-mediated eryth-
roid differentiation, another γ-globin inducer as well as
inhibitor of histone deacetylases [31]. Additionally, the
inhibition of histone deacetylases induced a high in-
crease of γ-globin mRNA and activated p38 signaling
during fetal hemoglobin stimulation [32].
Figure 3 Human G protein-coupled receptors signaling
pathway profile in erythroid progenitor cells. (A) Human GPCRs
Signaling Pathway related genes with increased expression at day 6
of erythroid progenitor cell culture of PB origin. Gene expression
was normalized to cyclophilin A. Control represents untreated cells.
(B) We analyzed erythroid progenitors at day 6 of culture after 48 hours
of treatment with 40 μM hydroxycarbamide. We presented only
hydroxycarbamide-induced genes using their symbols. Results are from
three independent experiments. *P < 0.05. Values are mean ± SEM.
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Symbol Gene names FL CB BM mPB PB 
GNL3  G protein-like 3 (nucleolar) ↑ ↑↑ 
GNL2  G protein-like 2 (nucleolar) ↑ 
GNAQ G protein, q polypeptide  ↑↑
GNAI2  
G protein, α inhibiting activity 
polypeptide 2  
GNAI3  
G protein, α inhibiting activity 
polypeptide 3 ↑ ↑ 
GNA11 G protein, α 11 (Gq class) ↓
GNA12 G protein α 12  
GNA13  G protein, α 13  ↑ 
GNA15  G protein, α 15 (Gq class)  ↑ ↑ 
GNB1  G protein, β polypeptide 1 ↓ 
GNB2L1  G protein, β polypeptide 2-like 1  
GNG2  G protein, γ 2  ↑ 
GNG10  G protein, γ 10 ↑ 
GRK6  GPR kinase 6  ↑ 
4RPG
GPR44    ↑ 
GPR45    ↑ 
GPR65    
GPR75    
88RPG ↑ 
GPR89C    ↑ 
GPR107    ↓ 
GPR108    ↓ 
GPR110    ↑ 
GPR135    ↑ ↓ 
GPR160    
GPR172A    ↑ ↑ 
ARRB1 Arrestin, beta 1 
ARRB2 Arrestin, beta 2 
ARRDC1 Arrestin domain containing 1 ↑
ARRDC2 Arrestin domain containing 2 
Figure 4 (See legend on next page.)
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We show that hydroxycarbamide stimulates GPCRs
PTGDR and PTGER1 gene expression. The activity of
PTGDR receptor is mediated by GαS proteins that stimu-
late adenylate cyclase resulting in an elevation of intracel-
lular cAMP and Ca2+, while PTGER1 mediates activity
through GαQ proteins that stimulate phosphatidylinositol-
calcium second messenger system (Figure 6) [33,34]. It
has been reported that expression of the γ-globin gene is
induced upon activation of the cAMP pathway, while
adenylate cyclase inhibition markedly decreased fetal
hemoglobin induction by hydroxycarbamide in human
erythroid cells [4,35]. Hydroxycarbamide increased intra-
cellular cGMP as well as cAMP levels in human erythroid
progenitors, while cAMP consecutively stimulates PKA
[11]. Phosphorylation of eNOS at Ser1177 by hydroxy-
carbamide was completely PKA dependent, accompanied
by a rise of the intracellular Ca2+ concentration [5].
Besides phosphorylation, eNOS production of NO is also
stimulated by increased intracellular Ca2+ levels and inter-
action with calmodulin (CaM). We demonstrated that NO
increased γ-globin gene expression in human erythroid
cells during differentiation. In addition, inhibition of sGC
prevents NO and hydroxycarbamide stimulation of γ-
globin gene expression [7]. Furthermore, sGC activators
or cGMP analogs augmented γ-globin gene expression in
primary human erythroblasts [36]. The NO–cGMP path-
way is known to increase JUN mRNA levels [37]. We
show that hydroxycarbamide increases GPCR-coupled
JUN gene expression, which is in accordance with previ-
ous studies related to induction of JUN and γ-globin gene
expression (Figure 6) [25,38]. It has been also postulated
that JUN activates the Gγ-globin promoter via an upstream
cAMP response element (CRE) in a way comparable to
transcription factor CRE binding protein 1 (CREB1) [39].
CREB2, a key transcription factor in erythropoiesis, was
down-regulated in Gpr48−/− fetal livers through the
cAMP-PKA-CREB pathway, with decreased adult hemo-
globin α and β chains [2]. There have been previous
reports of p38 MAPK increased phosphorylation by both
NO and cGMP [40,41]. Hydroxycarbamide also augmented
phosphorylation of p38, and demonstrated dependence
of p38 activity during stimulation of fetal hemoglobin
production [18]. Finally, the CREB1 activated γ-globin
expression via p38 MAPK signaling in erythroid
progenitors [42,43]. This observation emphasizes the
mutual stimulation of GPCRs and NO/cGMP pathway,
via JUN and p38 MAPK signaling, in activation of
γ-globin expression (Figure 6).
Figure 5 Principle of GPCR signaling. Acute agonist stimulation of GPCRs leads to activation of multiple signaling pathways, including second
messengers cAMP, IP3 and Ca2+. GPCRs in the plasma membrane couple to these pathways via G proteins that connect the receptors to
enzymes adenylyl cyclase, phospholipase C (PLC) or ionic conductance channels such as Ca2+ channels. Prolonged stimulation of the receptor
leads to recruitment to the cell membrane of β-adrenergic receptor kinases and β-arrestin. Detected genes by microarray are presented in
colored boxes corresponding to G protein isoforms (α, β, γ). The detected genes are upregulated (gray arrow) or downregulated (black arrow) vs.
HuURNA through ontogeny. PKA, protein kinase A; PKC, protein kinase C.
(See figure on previous page.)
Figure 4 G proteins and GPCRs expression in erythropoiesis during ontogenesis. Black boxes – decreased gene expression versus HuURNA,
dark gray boxes – increased gene expression, light gray boxes – no change in gene expression, white boxes – absent gene expression. G protein-
coupled receptor (GPR), guanine nucleotide binding protein (G protein), up arrow - significantly increased and down arrow - decreased gene
expression among examined erythroid progenitors.
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Conclusions
While mechanisms involved in globin gene expression
have been recognized at different levels within the regula-
tory hierarchy, relations among these molecular pathways
are only emerging. We associate our new results with the
NO/cGMP pathway described in our previous publi-
cations [6,7], and demonstrate the induction of G-proteins
and GPCR-coupled genes during γ-globin stimulation and
erythropoiesis through ontogeny. These genes and related
signaling pathways, involved in the mechanism of globin
activation, might be targets for the therapeutic agents to
upregulate γ-globin gene expression and fetal hemoglobin
levels in hemoglobinopathies. Therefore, further direct
studies are required to confirm that modifications in the
level of expression of GPCRs lead to significant changes in
NO/cGMP and other signaling pathways important for γ-
globin gene expression in erythroid cells.
Methods
Liquid erythroid cell cultures
For erythroid progenitor cell cultures, blood was
obtained from consenting normal volunteers from the
National Institutes of Health, Department of Transfusion
Medicine according to the regulations and guidelines of
the Office of Human Subjects Research. Adult PB mono-
nuclear cells are isolated from buffy coats of healthy
donors (3 individuals per experiment) using Lymphocyte
Separation Medium (BioWhittaker, Walkersville, MD).
We wash mononuclear cells twice with Dulbecco’s
phosphate-buffered saline (PBS, Invitrogen Corporation,
Carlsbad, CA), and CD34+ hematopoietic progenitors
are purified by positive immunomagnetic selection using
the MACS cell isolation system (Miltenyi Biotec,
Auburn, CA). Commercial FL- (Cambrex Bio Science,
Inc., Walkersville, MD), CB-, BM- and granulocyte-
colony stimulating factor (G-CSF) stimulated mobilized
PB- (mPB, AllCells LLC, Berkeley, CA) derived CD34+
cells are also collected by positive immunomagnetic
selection (Miltenyi Biotec). To stimulate erythroid differ-
entiation, the labeled CD34+ cells of all samples are
cultured in the medium that contains 30% fetal bovine
serum (FBS), 2 mmol/L glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin, 10% deionized bovine serum
albumin, 10 mmol/L mercaptoethanol, 1 mmol/L dexa-
methasone, 33 μg/ml holo-transferrin, 10 ng/ml SCF,
1 ng/ml IL-3 and 1 ng/ml GM-CSF (Sigma, St. Louis,
MO), and 1 U/ml human recombinant EPO (Amgen
Inc, Thousand Oaks, CA) [7]. For microarray analysis,
erythroid progenitors are isolated at day 6 of erythroid
cell culture at 37°C and 5% CO2 with balanced 95%
room air. At different time points during in vitro eryth-
roid differentiation, the viable cell counts are performed
with the use of a trypan-blue exclusion technique
(BioWhittaker).
Immunofluorescence analysis
After 6 days of erythroid culture, 5×105 cells are washed
in PBS containing 0.5% FCS and 0.02% sodium azide
and incubated for 20 minutes at the ambient tem-
perature in the presence of the appropriate monoclonal
antibodies at a twofold saturating concentration. Anti-
glycophorin-A (GlyA) FITC, anti-CD34 PE, anti-CD71
Figure 6 Induction of gamma-globin gene expression via GPCR signaling and NO-cGMP pathway. Stimulation of GPCRs (PTGDR and
PTGER1) in the plasma membrane leads to activation of NO-cGMP pathway via G proteins that connect the receptors to enzymes adenylyl cyclase
or ionic conductance channels generating second messengers’ cAMP and Ca2+. PKA – cAMP dependent protein kinase; CaM – calmodulin; CRE -
cAMP response element; (+p) phosphorylation, → stimulation, →O - translocation, ▲- experimentally documented hydroxycarbamide induction.
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Tricolor, anti-CD36-APC markers are used for cell
staining at day 6 of erythroid culture (Beckman-Coulter,
Miami, FL). Erythroid cells are then washed, fixed in PBS
containing 4% formaldehyde, and acquired on an LSRII
flow cytometer (BD Biosciences, San Jose, CA) equipped
with lasers emitting at wavelengths 355, 488, 532, 407 and
638 nm using DIVA4.1.2 software. The saturation of un-
specific binding sites is achieved by normal mouse serum
control present in the staining buffer. Data are analyzed
with Flowjo software (Tree Star, San Carlos, CA).
Isolation of total RNA
After 6 days of erythropoietin treatment and incubation
at 37°C (5% CO2, 95% humidity), we use the RNeasy
protocol for isolation of total RNA from erythroid pro-
genitor cells (Qiagen, Valencia, CA) according to the
manufacturer’s instructions. Concentration and integrity
of total RNA is assessed using an 8453 UV/Visible Spec-
trophotometer (Hewlett-Packard GmbH, Waldbronn,
Germany) and Agilent 2100 Bioanalyzer Software
(Agilent Technologies, Waldbronn, Germany) compar-
ing the ratio of 28S and 18S RNA peaks to ensure that
there is minimal degradation of the RNA sample. One
microgram of total RNA is reverse-transcribed with
SuperScript II RNase H- Reverse Transcriptase (Invitrogen
Corporation).
Quantitative PCR
Quantitative real-time PCR assay of γ- and β-globin
mRNA transcripts is carried out with the use of gene-
specific double fluorescently labeled probes in a 7700 Se-
quence Detector (Applied Biosystems, Foster City, CA).
The specific primers and TAQMAN probes (synthesized
by the NIDDK core oligonucleotide facility) are designed
using Primer Express software (Applied Biosystems) and
prepared on an ABI 394 synthesizer (Applied Biosystems)
as previously described [44]. Platinum Quantitative PCR
SuperMix-UDG (Invitrogen Corporation) is used for each
of the primer pairs containing a final concentration of
200 μM dNTPs, 0.5 μM Rox reference dye (Invitrogen
Corporation), 0.2 μM each of TAQMAN probe, forward
and reverse primers. Expression levels are determined
using the associated SDS software (ABI Prism, Applied
Biosystems) and Microsoft Excel (Redmond, WA). Stand-
ard curves are constructed using dilutions of an accurately
determined plasmid containing the cDNA of interest as
template.
Microarray studies
In microarray studies, the numbers of total genes
overexpressed in erythroid cells of CB, BM and PB ori-
gin are determined from three independent samples as
biological repeats at day 6 of erythroid liquid culture.
On the other hand in case of FL and mPB-derived
samples, the numbers of total overexpressed genes are
determined in independent duplicate samples at day 6 of
erythroid liquid culture. High quality oligonucleotide
glass arrays are produced containing a total of 16,659
seventy-mer oligonucleotides chosen from 750 bases of
the 30 end of each ORF (Operon Inc. Valencia, CA). The
arrays are produced in house by spotting oligo-
nucleotides on poly-L-lysine coated glass slides by Gene
Machines robotics (Omnigrid, San Carlos, CA). We have
followed the MIAME (minimum information about a
microarray experiment) guidelines for the presentation
of our data [45].
i) Probe preparation
Total human universal RNA (HuURNA) isolated
from a collection of adult human tissues to
represent a broad range of expressed genes from
both male and female donors (BD Biosciences, Palo
Alto, CA) serve as a universal reference control in
the competitive hybridization. All 5 blood tissues are
hybridized against HuURNA. The correlation
coefficients among those biological repeats
themselves are consistently ≥ 0.8, which
documented the quality of hybridization and
consistency of expression among the replicates of all
5 tissues. Labeled cDNA probes are produced as
described [46].
ii) Hybridization
For hybridization, 36 μl hybridization mixture
(cDNA mixture, 10 μg COT-1 DNA, 8–10 μg poly
(dA), 4 μg l yeast total RNA, 20X SSC and 10%
SDS) is pre-heated at 100°C for 2 minutes and
cooled for 1 minute. Total volume of probe is added
on the array and covered with cover slip. Slides are
placed in hybridization chamber and 20 μl water is
added to the slide, and incubated overnight at 65°C.
Slides are then washed for 2 minutes each in 2X
SSC, 1X SSC and 0.1X SSC and spin-dried.
iii) Data Filtration, normalization, and analysis
Microarray slides are scanned in both Cy3 (532 nm)
and Cy5 (635 nm) channels using Axon GenePix
4000B scanner (Axon Instruments, Inc., Foster City,
CA) with a 10-micron resolution. Scanned
microarray images are exported as TIFF files to
GenePix Pro 3.0 software for image analysis. For
advanced data analysis, gpr and jpeg files are
imported into microarray database, and normalized
by software tools provided by NIH Center for
Information Technology (http://nciarray.nci.nih.
gov). We gathered a set of 8,719 erythroid cells gene
expression data derived from 11 datasets that have
been posted on the National Center for
Biotechnology Information (NCBI) Gene Expression
Omnibus (GEO) database.
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Human G Protein-coupled receptors signaling pathway
finder gene array
Erythroid progenitor cells, of PB origin, are treated with
hydroxycarbamide at day 4 after stimulation with EPO
and incubated 48 hours at 37°C. At day 6, total RNA is
isolated. GPCRs array is completed using the GEArray
Q Series Chemiluminescence Detection User system
(SABiosciences, Frederick, MD). Briefly, the preheated
annealing mix with 2 μg of total RNA is added to label-
ing mix with biotin-16-dUTP (Roche Applied Science, In-
dianapolis, IN) and reverse transcriptase (Promega
Corporation, Madison, WI). The biotin labeled cDNA
probe is denatured before addition of the probe to the
hybridization solution with the GEArray Q Series mem-
brane. After hybridization with continuous agitation, and
washing, the chemiluminescent detection is performed.
We use a digital imaging system (FluorChem Imaging
system, Alpha Innotech Corporation, San Leandro, CA) to
record the chemiluminescent image of the array. The rela-
tive abundance of a particular transcript is estimated by
directly comparing its signal intensity to the signal derived
from a housekeeping gene cyclophilin A. The list of 110
genes for human GPCRs signaling pathway finder gene
array is available from the manufacturer (SABiosciences,
Frederick, MD).
Statistical analysis
The one way ANOVA Tukey’s Multiple Comparison tests
and paired t test are applied using Prism 4 software
(GraphPad Software Inc., San Diego, CA) for measure-
ment of statistical significance in cell growth and antigen
levels among blood tissues, as well as for γ- and β-globin
expression. For microarray data management and analysis,
we use NCI/CIT microArray database (mAdb) system.
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